[1]Tian XQ, Tan ZhY, Li XZh, et al. Expression of anoctamin 1 in the process of myocardial fibrosis[J]. Acta Anatomica Sinica, 2019,50(2),173-178.(in Chinese)
田香勤,谭朝阳,李新芝,等.氯离子通道蛋白1在心肌纤维化进程中的表达特征[J].解剖学报,2019,50(2),173-178.
[2]Schafer S, Viswanathan S, Vidjaja AA, et al. IL-11 is a crucial determinant of cardiovascular fibrosis[J]. Nature, 2017, 552(7683):110-115.
[3]Yu B, Li W, Al F, et al. MicroRNA-33a deficiency inhibits proliferation and fibrosis through inactivation of TGF-β/Smad pathway in human cardiac fibroblasts[J]. Pharmazie, 2017, 72(8): 456-460.
[4]Liu G, Ma C, Yang H, et al. Transforming growth factor β and its role in heart disease[J]. Exp Ther Med, 2017, 13(5): 2123-2128.
[5]Yan X, Zhang J, Pan L, et al. TSC-22 Promotes transforming growth factor β-mediated cardiac myofibroblast differentiation by antagonizing Smad7 activity[J]. Mol Cell Biol, 2011, 31(18): 3700-3709.
[6]Ding Y, Tao R, Zhang J, et al. Expression and significance of Smad2/3 and Smad7 in follicular cells of chemotherapy-induced premature ovarian failure in rats[J]. Acta Anatomica Sinica, 2018,49(4),497-505. (in Chinese)
丁艳,陶然,张静,等. Smad2/3与Smad7在大鼠化疗性卵巢早衰卵泡中的表达和意义[J].解剖学报, 2018,49(4),497-505.
[7]Yuan J, Chen H, Ge D,et al. Mir-21 promotes cardiac fibrosis after myocardial infarction via targeting Smad7[J]. Cell Physiol Biochem, 2017, 42(6):2207-2219.
[8]Nielsen SH, Willumsen N, Leeming DJ, et al. Assessment of activated fibroblasts by alpha-smooth muscle actin (α-SMA): a noninvasive biomarker of activated fibroblasts in lung disorders[J]. Transl Oncol, 2019, 2(2): 368-374.
[9]Serrano-Sevilla I, Artiga á, Mitchell SG, et al. Natural polysaccharides for siRNA delivery: nanocarriers based on chitosan, hyaluronic acid, and their derivatives [J]. Molecules, 2019 , 24(14): 2570.
[10]Tschöpe C, Ammirati E, Bozkurt B, et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions[J]. Nat Rev Cardiol, 2021, 18(3) : 169-193.
[11]Thakur N, Hamidi A, Song J,et al. Smad7 enhances TGF-β-induced transcription of c-Jun and HDAC6 promoting invasion of prostate cancer cells[J]. Science, 2020, 23(9): 101470.
[12]Yan X , Liao H, Cheng M. Smad7 protein interacts with receptor-regulated Smads (R-Smads) to inhibit transforming growth factor-β (TGF-β)/Smad signaling[J]. J Biol Chem, 2016 , 291 (1): 382-392.
[13]Yuan J, Chen H, Ge D. Mir-21 promotes cardiac fibrosis after myocardial infarction via targeting Smad7[J]. Cell Physiol Biochem, 2017, 42(6):2207-2219.
[14]SuDN , Wu SP, Xu SZ. Mesenchymal stem cell-based Smad7 gene therapy for experimental liver cirrhosis[J]. Stem Cell Res Ther, 2020 , 11(1):395.
[15]Wang Y, Huo YY, Zhang KT. Effect of Smad7 gene silencing on cell proliferation [J]. National Medical Journal of China,2004, 22(84):1909-1910. (in Chinese)
王莹, 霍艳英,张开泰. Smad7 基因沉默对细胞增殖的影响[J].中华医学杂志,2004, 22(84): 1909-1910.
[16]Fusco DD, Laudisi F, Dinallo V, et al. Smad7 positively regulates keratinocyte proliferation in psoriasis[J].Br J Dermatol, 2017, 177(6):1633-1643.
[17]Wang YL, Dong J, Wang L, et al. Effect of Smad7 on the proliferation and migration of hepatocellular carcinoma cells [J]. Progress in Modern Biomedicine, 2017,17(23):4437-4461. (in Chinese)
王玉林,董菁,王琳,等. Smad7 对肝癌细胞增殖和迁移的影响及其临床意义[J]. 现代生物医学进展, 2017,17(23):4437-4461.
[18]Kugler M, Schlecht A, Fuchshofer R. SMAD7 deficiency stimulates Müller progenitor cell proliferation during the development of the mammalian retina[J]. Histochem Cell Biol, 2017, 148(1):21-32.
[19]Espeland T, Lunde IG, Amundsen BH, et al. Myocardial fibrosis[J].Tidsskr Nor Laegeforen, 2018, 138(16).
[20]Garrido A, Djouder N. Cirrhosis: a questioned risk factor for hepatocellular carcinoma [J]. Trends Cancer, 2021,7( 1):29-36.
[21]Bracamonte-Baran W, ACˇGiháková D. Cardiac autoimmunity: myocarditis[J].Adv Exp Med Biol, 2017,1003:187-221.
[22]Duan Y, Zhu W, Liu M,et al. The expression of Smad signaling pathway in myocardium and potential therapeutic effects [J]. Histol Histopathol, 2017, 32(7): 651-659.
|